Tumor Necrosis Factor Inhibitors and Cancer in Juvenile Idiopathic Arthritis: Disentangling the Web

被引：5
|
作者：
Onel, Karen B. [1 ]
Onel, Kenan [1 ]
机构：
[1] Univ Chicago, Dept Pediat, Hematol Oncol Sect, Chicago, IL 60637 USA
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 04期
关键词：
RHEUMATOID-ARTHRITIS; RISK; METAANALYSIS; MALIGNANCY; LYMPHOMA; THERAPY; DISEASE;
D O I：
10.1002/art.34349
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：966 / 969
页数：4
相关论文
共 50 条
  • [41] Tumour necrosis factor inhibitors in enthesitis related arthritis and juvenile spondylarthropathies
    Horneff, Gerd
    [J]. EXPERT OPINION ON ORPHAN DRUGS, 2018, 6 (02): : 127 - 140
  • [42] Tumor Necrosis Factor Inhibitors and the Risk of Cancer among Older Americans with Rheumatoid Arthritis
    D'Arcy, Monica E.
    Beachler, Daniel C.
    Pfeiffer, Ruth M.
    Curtis, Jeffrey R.
    Mariette, Xavier
    Seror, Raphaele
    Mahale, Parag
    Rivera, Donna R.
    Yanik, Elizabeth L.
    Engels, Eric A.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2021, 30 (11) : 2059 - 2067
  • [43] Cyclophosphamide therapy for secondary amyloidosis in a patient with juvenile idiopathic arthritis unresponsive to tumor necrosis factor a inhibitor therapy
    Han, Sun Ae
    Yoon, Young Min
    Lee, Wan Soo
    Kim, Yun Sung
    Shin, Byung Chul
    Chung, Jong Hoon
    Kim, Hyun Lee
    [J]. KOREAN JOURNAL OF INTERNAL MEDICINE, 2016, 31 (03): : 601 - 604
  • [44] Insurance Status and Tumor Necrosis Factor Inhibitor Initiation Among Children With Juvenile Idiopathic Arthritis in the CARRA Registry
    Roberts, Jordan E.
    Williams, Kathryn
    Dallas, Johnathan
    Eckert, Mary
    Huie, Livie
    Smitherman, Emily
    Soulsby, William D.
    Zhao, Yongdong
    Son, Mary Beth F.
    [J]. JOURNAL OF RHEUMATOLOGY, 2023, 50 (08) : 1047 - 1057
  • [45] Septic abscess in a child with juvenile idiopathic arthritis receiving anti-tumor necrosis factor-α therapy
    Fitch, PG
    Cron, RQ
    [J]. JOURNAL OF RHEUMATOLOGY, 2006, 33 (04) : 825 - 825
  • [46] Clinical Remission in Patients with Systemic Juvenile Idiopathic Arthritis Treated with Anti-Tumor Necrosis Factor Agents
    Russo, Ricardo A. G.
    Katsicas, Maria M.
    [J]. JOURNAL OF RHEUMATOLOGY, 2009, 36 (05) : 1078 - 1082
  • [47] Abatacept for Severe Anti-Tumor Necrosis Factor α Refractory Juvenile Idiopathic Arthritis-Related Uveitis
    Zulian, Francesco
    Balzarin, Marta
    Falcini, Fernanda
    Martini, Giorgia
    Alessio, Maria
    Cimaz, Rolando
    Cimino, Luca
    Zannin, Maria Elisabetta
    [J]. ARTHRITIS CARE & RESEARCH, 2010, 62 (06) : 821 - 825
  • [48] Tumor Necrosis Factor α-308 GA/AA genotypes are associated with high inflammatory activity and high serum tumor necrosis factor α in Juvenile Idiopathic Arthritis patients.
    Mourao, Ana Filipa
    Cavaleiro, Joao
    Teles, José
    Sousa, Artur
    Costa, Paula
    Canhao, Helena
    Sobral, Marta
    da Costa, José Teixeira
    Gomes Pedro, Joao
    de Queiroz, Mário Viana
    Fonseca, Joao Eurico
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S694 - S694
  • [49] Tumor necrosis factor-α (TNFα) inhibitor-induced psoriasis in juvenile idiopathic arthritis (JIA) patients
    Groth, Daniel
    Lapidus, Sivia
    Nativ, Simona
    Perez, Maria
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69 : 74 - 75
  • [50] Switched Memory B Cells Are Increased in Oligoarticular and Polyarticular Juvenile Idiopathic Arthritis and Their Change Over Time Is Related to Response to Tumor Necrosis Factor Inhibitors
    Marasco, Emiliano
    Aquilani, Angela
    Cascioli, Simona
    Moneta, Gian Marco
    Caiello, Ivan
    Farroni, Chiara
    Giorda, Ezio
    D'Oria, Valentina
    Marafon, Denise Pires
    Magni-Manzoni, Silvia
    Carsetti, Rita
    De Benedetti, Fabrizio
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70 (04) : 606 - 615
12345